Met Life Investment Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 32,414 shares of RYTM stock, worth $1.92 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,414
Previous 33,498
3.24%
Holding current value
$1.92 Million
Previous $1.87 Million
8.33%
% of portfolio
0.01%
Previous 0.01%
Shares
40 transactions
Others Institutions Holding RYTM
# of Institutions
245Shares Held
62.9MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$399 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$360 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$342 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$332 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$204 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.3B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...